We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Test Kits Detect Mosquito Borne Diseases

By HospiMedica staff writers
Posted on 30 May 2007
As the mosquito season begins in different parts of the world, the demand for diagnostic test kits that detect mosquito-borne diseases is increasing.

The diagnostic test division of Medical Services International, Inc. More...
(Edmonton, Canada) was created in response to a worldwide demand for less costly, rapid, technically simplified test methods to test for infectious diseases. The company developed its VScan rapid test kits for the detection of HIV 1 and 2, hepatitis B and C, tuberculosis, dengue fever, and West Nile virus. The company is currently in negotiations with healthcare concerns to supply these tests to the worldwide market. Recently, the diagnostic division has been expanded to now offer test kits for sexual transmitted diseases (STDs) and for the initial detection of cancer. The STD kit tests are for syphilis and the cancer kit tests for prostate cancer. Other kits are under development.

To date, the VScan rapid human immunodeficiency virus (HIV) test kit has been approved in countries in South East Asia, and South and Central America. As a result, the VScan HIV 1 and 2 rapid test kit is now approved for sale at all levels including retail in countries representing approximately 40% of the world population.

Based on initial discussions with distributors, it appears that the company will supply in excess of 800,000 VScan test kits that detect mosquito-borne diseases during this mosquito season.


Related Links:
Medical Services International

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.